NCT03714191

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

Using Rapid Cycle Randomized Controlled Trials to Study a Tobacco Cessation Best Practice Advisory.

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 54,417 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare \& Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

Conditions

• Tobacco Use Cessation

Interventions

Type	Name	Description
OTHER	Patient Outcomes	The intervention includes different versions of the BPA design and message.
OTHER	Billing documentation	The intervention includes different versions of the BPA design and message.
OTHER	Regulatory	The intervention includes different versions of the BPA design and message.

Timeline

• Start date: 2018-10-03
• Primary completion: 2019-05-24
• Completion: 2020-02-29
• First posted: 2018-10-22
• Last updated: 2021-07-21

Locations

1 site across 1 country: United States